Delivery Order SPE2DB22D2218-SPE2DB24FR1YP
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,329,848 units of insulin aspart 100 unit/mL pen 3mL. The contract has a potential value of $18,352.18 and a completion date of January 16, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that has received numerous awards from DLA to supply...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,637.56 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,298,990 units of Insulin Aspart 100 Unit/mL pen 3mL. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC allows the DLA to efficiently procure a...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 10 mL vials of Insulin Aspart 100 unit/mL. The $9,493 delivery order was placed under a larger contract held by Amerisourcebergen Drug Corp to supply pharmaceuticals, medical supplies, and related distribution services to DLA. The order has a completion date of January 19, 2024 and does not have a set-aside...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,822.60, is for the delivery of Insulin Aspart 100 Unit/ML Vials 10ML to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,335,048 units of Insulin Aspart 100 Unit/mL Pen 3mL. The $20,817.40 delivery order has a completion date of January 17, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has previously received numerous federal contract awards from DLA Troop Support Medical to provide pharmaceuticals, medical supplies, and...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Insulin Aspart 100 Unit/mL in 10 mL vials. The firm-fixed-price delivery order contract, valued at $4,650.75, does not have a set-aside designation and has an ultimate completion date of August 30, 2024. Amerisourcebergen, through its Corporate Office Division, has been awarded numerous indefinite delivery...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,337,566 units of Insulin Aspart 100 Unit/mL Pen 3mL. The $12,081.09 delivery order has a completion date of January 17, 2024 and was awarded on January 16, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has previously received numerous federal contracts from DLA Troop Support Medical to supply...
- The U.S. Department of Defense's Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,299,186 units of Insulin Aspart 100 Unit/mL Pen 3mL. The $3,659.20 delivery order has a completion date of January 11, 2024. AmerisourceBergen Drug Corp is a prime contractor that has received numerous federal contract awards from the DLA to supply pharmaceuticals, medical...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,195.52, is for the provision of Insulin Aspart 100 unit/mL pens with a completion date of January 31, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is part of a larger indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,659.20 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order is for the delivery of insulin aspart 100 unit/ml pen 3ml to support DLA Troop Support Medical operations. This delivery order is part of Amerisourcebergen Drug Corp's existing indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies. No...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB24FR1YPDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,436,064 units of Insulin Aspart 100 unit/mL vials. The contract has a potential value of $5,426.62 and a completion date of January 25, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that has received numerous federal contract awards to supply pharmaceuticals, medical supplies, and distribution services to DLA Troop Support Medical facilities. This delivery order is part of DLA's broader efforts to provide critical care supplies and medications to military treatment programs and facilities. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 1/24/24 |